AAX Biotech is attending BIO 2024
AAX Biotech will be represented by CEO Maria Lisa Knudsen at BIO 2024 in San Diego (June 3-6)!
We are looking forward to meeting with current and future pharma partners to discuss drug development, and how our unique technologies Seqitope™ and Opti-mAb™ accelerate drug development and enable the development of next-generation antibody therapeutics that are more efficient and have higher developability.
Please feel free to connect with us if you are attending too!
